{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:51:05Z","timestamp":1793652665879,"version":"4.5.1"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This is a comprehensive review of the current knowledge on predominant immune cell phenotypes involved in idiopathic inflammatory myopathies (IIM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Major circulating immune cell subpopulations described in IIM encompass the lymphocyte compartment. An unbalance in T cell subsets seems to consistently affect the peripheral and muscle compartment, with a predominance of CD4+ T and B cells in dermatomyositis, CD8+ T cells in polymyositis\/inclusion body myositis (IBM) and novel findings highlighting novel proinflammatory T subsets, that is, CD8+Tbet+ and CD28\u2212 T cells across different IIM subsets. On the other hand, an impairment in Treg cells number and function has been described especially across polymyositis\/dermatomyositis and IBM. Total T follicular helper (Tfh) cells, increased in immune-mediated necrotizing myopathy, skewed toward Tfh2 and Tfh17 in dermatomyositis, polymyositis, and juvenile dermatomyositis. B cell compartment is more rarely described in IIM, yet an unbalance in this pool is as well likely. Evidence of plasma cells increased in polymyositis, dermatomyositis, IBM, and Bregs decreased in dermatomyositis have been reported. Perturbations in the memory and na\u00efve subsets are common in dermatomyositis\/polymyositis and antisynthetase syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Protean immune cell abnormalities characterize different IIM subsets, reflecting the complexity of these autoimmune conditions. A deeper understanding of B-cell and T-cell immunophenotyping may promote early diagnosis and identification of new potential therapeutic targets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000831","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T11:16:02Z","timestamp":1629198962000},"page":"522-528","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Lymphocyte immunophenotyping in inflammatory myositis: a review"],"prefix":"10.1097","volume":"33","author":[{"given":"Chiara","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/BOR.0000000000000748","article-title":"Nonimmune mechanisms in idiopathic inflammatory myopathies","volume":"32","author":"Loredo Martinez","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/BOR.0000000000000663","article-title":"Pulmonary involvement in antisynthetase syndrome","volume":"31","author":"Gasparotto","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.573347","article-title":"Crosstalk between innate and T cell adaptive immunity with(in) the muscle","volume":"11","author":"Bonomo","year":"2020","journal-title":"Front Physiol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s13317-014-0062-2","article-title":"Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis","volume":"5","author":"Vattemi","year":"2014","journal-title":"Autoimmun Highlights"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/bjd.15607","article-title":"The pathogenesis of dermatomyositis","volume":"179","author":"Thompson","year":"2018","journal-title":"Br J Dermatol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4137\/CMAMD.S10272","article-title":"Phenotypes of peripheral blood lymphocytes and cytokine expression in polymyositis and dermatomyositis before treatment and after clinical remission","volume":"5","author":"Shimojima","year":"2012","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2044-5040-3-13","article-title":"Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness","volume":"3","author":"Rayavarapu","year":"2013","journal-title":"Skelet Muscle"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.579043","article-title":"Role of extracellular vesicles in autoimmune pathogenesis","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"247","DOI":"10.14336\/AD.2020.0410","article-title":"The role of immune cells in the pathogenesis of idiopathic inflammatory myopathies","volume":"12","author":"Zhao","year":"2021","journal-title":"Aging Dis"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/annrheumdis-2019-215046","article-title":"Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups","volume":"78","author":"Rothwell","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/BOR.0000000000000548","article-title":"New insights in myositis-specific autoantibodies","volume":"30","author":"Ghirardello","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11926-013-0335-1","article-title":"Autoantibodies in polymyositis and dermatomyositis","volume":"15","author":"Ghirardello","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","article-title":"Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort","volume":"384","author":"Tarricone","year":"2012","journal-title":"J Immunol Methods"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2020-000639","article-title":"CD8+ CD57+ T cells exhibit distinct features in human nonsmall cell lung cancer","volume":"8","author":"Huang","year":"2020","journal-title":"J Immunother Cancer"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jneuroim.2019.04.014","article-title":"Mass cytometry reveals an impairment of B cell homeostasis in antisynthetase syndrome","volume":"332","author":"Dzangu\u00e9-Tchoupou","year":"2019","journal-title":"J Neuroimmunol"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.autrev.2019.02.003","article-title":"CD8+ T-bet+ cells as a predominant biomarker for inclusion body myositis","volume":"18","author":"Dzangu\u00e9-Tchoupou","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1212\/WNL.66.4.493-a","article-title":"Erratum: Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"66","author":"Greenberg","year":"2006","journal-title":"Neurology"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55563\/clinexprheumatol\/qug8tf","article-title":"One year in review 2020: idiopathic inflammatory myopathies","volume":"39","author":"Zanframundo","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3899\/jrheum.121031","article-title":"Longitudinal peripheral blood lymphocyte subsets correlate with decreased disease activity in juvenile dermatomyositis","volume":"40","author":"Ernste","year":"2013","journal-title":"J Rheumatol"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12016-016-8527-x","article-title":"The immune response and the pathogenesis of idiopathic inflammatory myositis: a critical review","volume":"52","author":"Ceribelli","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R25-20250526","first-page":"1","article-title":"Decreased serum 25-(OH)-D level associated with muscle enzyme and myositis specific autoantibodies in patients with idiopathic inflammatory myopathy","volume":"12","author":"Yu","year":"2021","journal-title":"Front Immunol"},{"key":"R26-20250526","article-title":"Circulating regulatory T cells were absolutely decreased in dermatomyositis\/polymyositis patients and restored by low-dose IL-2","author":"Zhang","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multicenter study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-020-02412-8","article-title":"Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in antisynthetase syndrome patients","volume":"23","author":"Young-Glazer","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R31-20250526","first-page":"1","article-title":"Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis \u2013 challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J Transl Autoimmun"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190411","article-title":"Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: a retrospective observational study","volume":"13","author":"Ha","year":"2018","journal-title":"PLoS One"},{"key":"R34-20250526","first-page":"1","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"1","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/1873-3468.12733","article-title":"Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles","volume":"591","author":"de Candia","year":"2017","journal-title":"FEBS Lett"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7150\/ijbs.39629","article-title":"Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases","volume":"16","author":"Tian","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.autrev.2017.07.016","article-title":"How I treat idiopathic patients with inflammatory myopathies in the clinical practice","volume":"16","author":"Cavagna","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","article-title":"Current diagnosis and treatment of polymyositis and dermatomyositis","volume":"28","author":"Sasaki","year":"2018","journal-title":"Mod Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:32Z","timestamp":1748296832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000831","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]}}}